PubMed=2910432; DOI=10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N
Geisinger K.R., Kute T.E., Pettenati M.J., Welander C.E., Dennard Y., Collins L.A., Berens M.E.
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.
Cancer 63:280-288(1989)

PubMed=9698466; DOI=10.1006/gyno.1998.5039
Maxwell G.L., Risinger J.I., Tong B., Shaw H., Barrett J.C., Berchuck A., Futreal P.A.
Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.
Gynecol. Oncol. 70:13-16(1998)

PubMed=9769151; DOI=10.1007/s11626-996-0015-9
Baldwin W.S., Curtis S.W., Cauthen C.A., Risinger J.I., Korach K.S., Barrett J.C.
BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro.
In Vitro Cell. Dev. Biol. Anim. 34:649-654(1998)

PubMed=22328975; DOI=10.1158/2159-8290.CD-11-0170
Hanrahan A.J., Schultz N., Westfal M.L., Sakr R.A., Giri D.D., Scarperi S., Janakiraman M., Olvera N., Stevens E.V., She Q.-B., Aghajanian C., King T.A., de Stanchina E., Spriggs D.R., Heguy A., Taylor B.S., Sander C., Rosen N., Levine D.A., Solit D.B.
Genomic complexity and AKT dependence in serous ovarian cancer.
Cancer Discov. 2:56-67(2012)

PubMed=22710073; DOI=10.1016/j.ygyno.2012.06.017
Korch C.T., Spillman M.A., Jackson T.A., Jacobsen B.M., Murphy S.K., Lessey B.A., Jordan V.C., Bradford A.P.
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.
Gynecol. Oncol. 127:241-248(2012)

PubMed=25321415; DOI=10.1210/me.2014-1229
Li Y., Arao Y., Hall J.M., Burkett S.S., Liu L.-W., Gerrish K., Cavailles V., Korach K.S.
Research resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.
Mol. Endocrinol. 28:2072-2081(2014)